The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article
… it seems only logical to review a drug that has worked efficiently against a disease-causing agent
… available in a form that is safe for human consumption since the early 1980 s
… discovered and developed by William C. Campbell and Satoshi Ōmura for which they received the Nobel Prize
… a well-established formulation development
… as well as pharmacokinetic and pharmacodynamic profiles
… drugs received Emergency Use Authorization for COVID-19 treatment with unsatisfactory supportive data
… Ivermectin … has been sidelined irrespective of sufficient convincing data supporting its use
… the longevity of the immunity offered by these vaccines
… protection against new mutant strains
… The probability that an ineffective treatment generated results as positive for the 55 studies to date is estimated to be 1 in 23 trillion (p = 0.000000000000043)
